Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Six degrees head-down tilt bed rest caused low-grade hemolysis: a prospective randomized clinical trial


This study aimed to measure hemolysis before, during and after 60 days of the ground-based spaceflight analog bed rest and the effect of a nutritional intervention through a prospective randomized clinical trial. Twenty male participants were hospitalized for 88 days comprised of 14 days of ambulatory baseline, 60 days of 6° head-down tilt bed rest and 14 days of reambulation. Ten participants each received a control diet or daily polyphenol associated with omega-3, vitamin E, and selenium supplements. The primary outcome was endogenous carbon monoxide (CO) elimination measured by gas chromatography. Hemolysis was also measured with serial bilirubin, iron, transferrin saturation blood levels and serial 3-day stool collections were used to measure urobilinoid excretion using photometry. Total hemoglobin mass (tHb) was measured using CO-rebreathing. CO elimination increased after 5, 11, 30, and 57 days of bed rest: +289 ppb (95% CI 101–477 ppb; p = 0.004), +253 ppb (78–427 ppb; p = 0.007), +193 ppb (89–298 ppb; p = 0.001) and +858 ppb (670–1046 ppb; p < 0.000), respectively, compared to baseline. Bilirubin increased after 20 and 49 days of bed rest +0.8 mg/l (p = 0.013) and +1.1 mg/l (p = 0.012), respectively; and iron increased after 20 days of bed rest +10.5 µg/dl (p = 0.032). The nutritional intervention did not change CO elimination. THb was lower after 60 days of bed rest −0.9 g/kg (p = 0.001). Bed rest enhanced hemolysis as measured through all three by-products of heme oxygenase. Ongoing enhanced hemolysis over 60 days contributed to a 10% decrease in tHb mass. Modulation of red blood cell control towards increased hemolysis may be an important mechanism causing anemia in astronauts.


Space anemia after exposure to microgravity was first observed in six astronauts from Gemini missions1. Later studies correcting for environmental oxygen concentrations failed to resolve the anemia in 4 returning astronauts from the Spacelab 1 mission2. Further experiments identified a 10–15% decrease in erythrocyte mass measured in three astronauts after 9 days3 and in six astronauts after 9 and 14 days in space4. More recently, longer-duration space missions followed erythropoietic adaptation to space after the initial 10 days and reported no anemia onboard the ISS throughout 6-month missions questioning whether space anemia was real or had been resolved with modern space travel5. However, epidemiological data from over 5 decades of American and Canadian presence in space confirmed and characterized space anemia6.

The search for mechanisms to explain space anemia has generated multiple hypotheses and experiments over the past decades such as: ineffective erythrocyte production and/or egress from the bone marrow3,7,8, low erythropoietin levels or sensitivity3,4, and production of abnormally-shaped erythrocytes9. In situations of hemoconcentration the excess erythrocytes can be sequestered in the spleen7, remain in circulation until time-determined senescence3, or their lifespan can be shortened preferentially affecting young erythrocytes4 or equally affecting erythrocytes of all ages10.

Hemolysis regulates erythropoietic homeostasis11,12,13. Alfrey proposed that upregulated hemolysis explained the decrease in total hemoglobin mass (tHb) using data obtained by labeling erythrocytes3,4. However, this evidence for hemolysis was indirect14. Volunteers exposed to bed rest with 6° head-down tilt (HDT) also displayed lower tHb upon reambulation15,16,17. Clinically, an abundance of data demonstrates an association between bed rest and anemia18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35. However, there has been debate over whether this might be caused by a reduction in erythropoiesis, an increase in hemolysis, or both. Our trial sought to answer that question. In parallel, the effectiveness of a nutritional intervention of food plants, vitamin E and omega-3 at preventing deconditioning induced by bed rest was investigated. Its effect on hemolysis is unknown and was assessed36,37,38.

Hemolysis can be quantified directly by measuring degradation products of hemoglobin. Senescent red blood cells (RBC) release hemoglobin molecules. Each of the four heme rings is enzymatically degraded by heme oxygenases (HO)11 producing equimolar amounts of CO, biliverdin and ferrous ion12,13. Hemoglobin heme is the largest source of endogenous CO (85%), which allows attributing changes in CO elimination at the lungs to changes in the steady-state rate of hemolysis39,40. CO elimination is the difference between alveolar and ambient CO concentrations ([CO]) at a stable ventilation rate. Each molecule of biliverdin from heme degradation is conjugated in the liver to bilirubin, excreted in the intestine, converted to urobilinoids and eliminated in the feces41. Finally, serum iron levels and iron-related proteins can be measured in the serum.

Our objectives were to assess: (1) the effect of exposure to 60 days of bed rest HDT, and (2) the effect of a nutritional intervention on hemolysis in 20 volunteers using carbon monoxide (CO) elimination as the primary outcome; (3) To assess the effect of hemolysis on tHb mass. Our hypotheses were that: (1) exposure to bed rest HDT will increase hemolysis while (2) a nutritional intervention will have no effect; and (3) prolonged durations of increased hemolysis will contribute to anemia.


All participants (mean age 34.2 [SD, 7.8] years) completed the study (Fig. 1). There was no effect of the nutritional intervention on hemolysis (Supplementary Table 1 and Supplementary Fig. 1). Therefore, participants’ data were combined (n = 20) to analyze the effect of exposure to bed rest on hemolysis.

Fig. 1: CONSORT flow diagram for transparent reporting of trials.
figure 1

CO data from 1 participant at R30 was excluded due to admitted environmental factors (cigarette smoking). Blood was not drawn on three participants at reambulation Day 30. Stool samples were not collected for one participant at HDT11,12,13. Total Hb mass determination was excluded for three participants due to technical difficulties.

Hemolysis markers

Baseline CO elimination was 1795ppb (95% CI: 1644–1947ppb; Table 2). CO elimination was higher after 5, 11, 30, and 57 days of bed rest compared to baseline: +289 ppb (101–477 ppb), +253 ppb (78–427 ppb), +193 ppb (89–298 ppb) and +858 ppb (670–1046 ppb), respectively; (Fig. 2a). The average increase in CO elimination during bed rest was 23%. CO elimination measured at reambulation days 5, 12, and 30 were comparable to baseline. Results from the two campaigns were comparable (Supplementary Fig. 2).

Fig. 2: Measures of the three by-products of heme degradation by the hemoglobin oxygenase enzymes in 20 male participants before, during and after 60 days of bed rest HDT.
figure 2

a Endogenous CO elimination was elevated at all time points during bed rest. b Iron levels were elevated after 20 days of bed rest and decreased below baseline after bed rest. c Bilirubin was elevated at all time points during bed rest. These findings support low-grade hemolysis with enforcing and maintaining the bed rest position. Data expressed as changes from baseline. Shaded area represents the bed rest HDT phase. BDC baseline data collection, HDT head-down tilt, R recovery or reambulation. Error bars: 95% confidence interval. *p < 0.05 compared to baseline.

Iron was higher after 20 days of bed rest: +10.5 µg/dl (1.0–19.9 µg/dl) compared to baseline (Fig. 2b). The average increase in serum iron during bed rest was 14%. Iron was lower than baseline at reambulation days 13 and 30 (Fig. 2b and Table 1).

Table 1 Quantification of hemolysis using measures of heme degradation products.

Total bilirubin was higher after 20 and 49 days of bed rest compared to baseline, +0.8 mg/l (0.2–1.4 mg/l) and +1.1 mg/l (0.3–1.8 mg/l), respectively (Fig. 2c). The average increase in total bilirubin during bed rest was 19%.

Urobilinoids elimination was higher after 11-12-13, 30-31-32, and 56-57-58 days of bed rest: +75.9 mg/day (−15.4–167.2 mg/day), +33.3 mg/day (−31.0–97.5 mg/day) and +49.2 mg/day (−29.6–128.0 mg/day), respectively (Table 1) but the confidence intervals included zero. The average increase in urobilinoids elimination during bed rest was 20%.

The transferrin saturation was higher after 49 days of bed rest: +4.1% (0.3–8.0%; Table 1). The average increase in transferrin saturation during bed rest was +15%. Transferrin saturation was lower at reambulation days 13 and 30. Haptoglobin was unchanged throughout bed rest (Table 2).

Table 2 Erythropoietic markers. Data (95% CI) for erythropoietic markers before, during, and after bed rest.

Erythropoietic markers

Red blood cell concentration was higher after 20, 49, and 60 days of bed rest: +48.2 104/mm3 (3.8–5.8 104/mm3); +47.8 104/mm3 (3.5–6.1 104/mm3), and +27.4 104/mm3 (1.6–3.9 104/mm3), respectively, compared to baseline (Fig. 3a). The average increase in red blood cell concentration during bed rest was 9%. Red blood cell concentration was lower at reambulation day 13 (Fig. 3a and Table 2). Mean hemoglobin concentrations were −0.55 g/dl (−0.9 to −0.2 g/dl) and −0.46 g/dl (−0.9 to −0.1 g/dl) at reambulation days 13 and 30, respectively (Table 2).

Fig. 3: Erythropoietic changes in 20 male participants before, during and after 60 days of bed rest HDT.
figure 3

a Participants remained hemoconcentrated at all time points during bed rest. Reambulation uncovered lower RBC concentration. b EPO was decreased at all time points during bed rest. EPO increased at reambulation. c Total hemoglobin mass was decreased after 60 days of bed rest and at recovery Day 7. Sixty days of bed rest caused a 77.2 g loss in tHb mass attributed to hemolysis and blood draws. Data expressed as changes from baseline. Shaded area represents the bed rest HDT phase. BDC: Baseline Data Collection; HDT: Head-Down Tilt; R: Recovery or Reambulation. Error bars: 95% Confidence Interval. *p < 0.05 compared to baseline.

EPO was lower after 20 and 49 days of bed rest: −3.3 mUI/ml (−4.7 to −2.0 mUI/ml), and −2.1 mUI/ml (−3.4 to −0.7 mUI/ml); respectively, compared to baseline (Fig. 3b). The average decrease in EPO during bed rest was 18%. EPO was higher than baseline at reambulation days 13 and 30.

Total hemoglobin mass was significantly lower after 60 days of bed rest and at reambulation day 7: −0.9 g/kg (−1.4 to −0.4 g/kg) and −1.3 g/kg (−1.7 to −1.0 g/kg), respectively, compared to baseline (Fig. 3c). The average decrease in tHb mass between baseline and 60 days of bed rest was 10% (Table 2).

Reticulocyte concentrations were unchanged during bed rest (Table 2) but were higher than baseline at reambulation days 13 and 30: +16.6 103/µl (0.9–2.4 103/µl) and +10.8 103/µl (0.3–1.9 103/µl), respectively.


This prospective randomized clinical trial provided the first direct confirmation of enhanced hemolysis using the bed rest space analog model. In healthy men, CO elimination increased on average 23%. The other heme degradation products were also elevated throughout bed rest (bilirubin + 19%, urobilinoids +20%, iron +14% and transferrin saturation +15%). The difference in percent increase between the 3 by-products of heme oxygenase may be explained by their individual metabolic pathways. Bilirubin clearance accrues when production increases,42 in addition, the buffering of iron by various proteins43 may also decrease their levels. CO is not further degraded and constitutes a reliable marker of hemolysis44. Participants’ enhanced hemolysis was synchronous with the bed rest position. All hemolysis markers increased from the first measures, remained elevated throughout the 60 days of bed rest, and returned to or below baseline levels at reambulation. Taken together, the increased levels of the three heme by-products in synchrony with bed rest confirmed our first hypothesis that exposure to bed rest HDT (head-down-tilt) increases hemolysis. The nutritional intervention designed to prevent deconditioning showed no effect on hemolysis, which confirmed the second hypothesis.

Sustained increased hemolysis can contribute to anemia. The participants in the current study experienced a mean 10% decrease in tHb mass at day 60 of bed rest. In fact, the hemoglobin concentration of 9/20 participant reached clinical anemia levels45 at day 13 of reambulation (Table 2) confirming our third hypothesis. Increased hemolysis during bed rest in the HDT position may be related to low EPO, bone marrow unloading and circadian cycle.

Increased hemolysis was associated with an 18% decrease in EPO levels throughout bed rest. Low EPO levels have also been consistently reported with space missions46. They were interpreted as a response to hemoconcentration that triggered peripheral hemolysis of young RBC to rapidly return RBC concentration to normal levels4,10,46,47,48. In this trial, participants remained hemoconcentrated (+9%), however, the unchanged reticulocyte concentration argued against their preferential hemolysis. Also, low EPO, hemoconcentration, and increased hemolysis persisted for 60 days and were not a rapid adaptation to the initial days of bed rest. Persistently low EPO levels with bed rest may participate directly or indirectly to hemolysis in the bone marrow. Erythroid progenitors and early erythroblasts are continuously generated in large excesses and the fraction surviving to complete differentiation is regulated by EPO levels49. Haptoglobin binds to free plasma hemoglobin; the unchanged haptoglobin levels in this study supported a predominantly extravascular mechanism of hemolysis50,51,52. Importantly, while low-grade hemolysis physiologically attenuated hemoconcentration, it was an inappropriate response to a low tHb mass (Fig. 3c), which can contribute to anemia.

Bed rest unloads the skeleton and, therefore, the hemopoietic bone marrow. Mechanosensitive osteolineage cells directly interact with hemopoietic stem cells around bone marrow sinusoids53,54,55. While exercise stimulates erythropoiesis, the elimination of axial loading imposed by bed rest may inhibit RBC production56,57. Skeletal offloading can also impair hematopoiesis via the bone marrow adipose tissue (MAT)54,55. Inactivity increases MAT, which can impair hematopoiesis by occupying space and/or through paracrine action58. Tight reciprocal relationship between MAT and hematopoiesis59,60 support that adipocytes are negative regulators of hematopoietic stem cell55. Low EPO has also been shown to favor adipogenesis61. Each marrow adipocyte in the mouse displaced ~30 hematopoietic cells59 and could interact with more than 100 through direct contact or via reticular macrophages of the erythroblast islands62. Increased MAT can impede the migration of maturing erythroid cells from the erythroblast islands to the sinusoids for egress into circulation63 and increase hemolysis locally in the bone marrow. Fluid shift to the bone marrow may, similar to MAT increase ineffective erythropoiesis.

Enforced bed rest disrupts the activity cycle between daytime and nighttime. Aborting circadian oscillations may alter erythrocyte control since both heme synthesis and degradation molecules are central actors in multiple internal clocks and metabolic pathways64,65. Heme binding to CLOCK protein regulates circadian control66. Both heme biosynthesis enzyme delta-aminolevulinate synthase 1 and hemolysis enzymes HO in liver followed a circadian expression67,68,69. Expression of HO mRNA in the retina peaked in the morning and middle of the night11. Klemz showed that rhythmic heme degradation was required for normal circadian rhythms, possibly through CO signaling70. Bed rest abolished the oscillatory verticalization for 60 days and may have shifted the circadian cycle-dependent erythropoiesis-hemolysis balance towards increased hemolysis.

At reambulation, hemolysis levels readily returned to baseline; and reversed fluid shift resulted in decreased RBC concentration (Figs 2 and 3). This was accompanied by a strong erythropoietic response with increased EPO levels and reticulocyte concentrations to palliate the low RBC concentration and tHb mass. Both iron and transferrin saturation dropped below normal levels possibly reflecting iron mobilization for intense erythropoiesis and iron losses from blood draws.

Since bed rest HDT is a microgravity analog, persistently increased hemolysis supports continued astronaut monitoring throughout space missions since space anemia worsens with increasing duration of exposure to microgravity6.

Beyond applications to space medicine, these results may apply on Earth to patients with reduced mobility24 and the elderly27,28. These populations spend increased time in bed or in wheelchairs and suffer high prevalence of chronic anemia of unexplained etiology25,26,27,28,29,71,72,73,74. Our findings of low-grade hemolysis in healthy volunteers with enforced reduced mobility is novel but the study did not include a horizontal bed rest group. However, Mitlyng et al. had identified a similar 25% shorter RBC lifespan in patients with arthritis limiting mobility and with chronic anemia75. Therefore, low-grade hemolysis may be the mechanism explaining the high prevalence of anemia in patients who remain bedridden for prolonged durations76,77,78,79,80. In these patients, different approaches may be needed to address increased hemolysis with bed rest. Should MAT accumulation be a major contributor, antagonists of the peroxisome proliferator-activated receptor-γ may be favored81. Should skeleton unloading or circadian dysregulation be culprits, minimizing time in bed with early mobilization and promoting physical activity may be beneficial. Finally, serum adenosine levels were found to be enhanced with hemolysis and in a hypoxic bedridden environment, and adenosine can modulate important metabolic processes as well as the immune response82.

There are several limitations associated with the presented work. Parallel investigations during this bed rest study required venipunctures of 483 ml between baseline and day 60 of bed rest (Supplementary Fig. 3). Despite iron losses arising from the venipunctures, increased iron/transferrin saturation during bed rest indicated its enhanced release. Similarly, venipunctures participated in lowering the tHb mass, which could have lowered CO elimination proportionately. Again, a 23% increase in CO elimination was measured from a 10% smaller pool of RBCs further supporting enhanced hemolysis during bed rest. Concomitant investigations required biopsies of muscle and fat at baseline and bed rest Day 56. Myoglobin and cytochrome degradation may have increased CO elimination. CO at baseline appeared unaffected but biopsies may have contributed to the Day 57 CO elimination data (Fig. 2 and Supplementary Fig. 4). Owing to the small sample size and targeted physiological outcomes, we did not correct for multiple hypothesis-testing. Since all of baseline measures but one were carried out between BDC-4 and BDC-1, they corresponded to the status within 4 days of the bed rest phase.

The ground-based spaceflight analog head-down tilt bed rest triggered enhanced hemolysis measured with all three by-products of heme degradation. Persistent hemolysis over 60 days contributed to lower tHb mass. These results suggest that enhanced hemolysis may constitute one important mechanism linking anemia with microgravity in astronauts and anemia with bed rest on Earth.


Subjects and setting

The study was sponsored by the Center National d’Etudes Spatiales and collaborator the European Space Agency. The study was approved by the Comité de protection des personnes Sud-ouest et outre-mer (ID-RCB:2016-A00401-50), the Ottawa Health Science Network REB (20160925-01H) and registered at NCT03594799 (Date submitted: November 24 2017; Date posted: July 20 2018). Informed consent was obtained from all individual participants included in the study and all participants signed informed consent regarding publication of their data. The study ran at the MEDES space clinic in France between January 2017 and January 2018. A volunteer sample of 20 men were recruited via the clinic website and the media. Inclusion criteria included age (20 to 45years) and BMI (22 to 27 kg/m2). Exclusions included hematological diseases, recent blood donation, smokers and active medical treatment (Supplementary Detail 1). The sample size was selected to detect a change in fasting plasma triglycerides concentration with the nutritional intervention. Sixteen research groups carried out various investigations in parallel, which constrained the sampling schedule and explained the variable sampling times between outcome measures.

Design, exposure, and intervention

This prospective randomized clinical trial tested a nutritional intervention to prevent deconditioning from exposure to bed rest head-down tilt (HDT). The design included 2 identical campaigns of 10 volunteers starting 8 months apart. Each campaign was comprised of 14 days of baseline data collection (BDC), followed by 60 days of bed rest HDT, 14 days of recovery or reambulation (R), with follow-up at R30. The nutritional intervention consisted of half the participants receiving daily 741 mg polyphenols, 2.1 g Omega-3, 168 mg vitamin E and 80 µg selenium (detailed nutritional intervention in Supplementary Detail 2).

Quantification of hemolysis

We quantified the three by-products of hemoglobin degradation by heme oxygenase. Alveolar and ambient air samples to measure CO concentrations ([CO]) were collected at eight time points, one during baseline data collection (BDC-1), four during bed rest (HDT5, HDT11, HDT30, HDT57), and three during reambulation (R5, R12, R30) (Supplementary Fig. 5). A ninth measure at BDC-14 was dropped due to equipment failure at study outset (Supplementary Fig. 6). CO elimination was performed according to Shahin83, which involves replication of the measures, and implemented major improvements over prior methods15. Briefly, alveolar and ambient air samples were collected upon waking at 07:00 hours. Alveolar air collection followed 20 s of breath holding. On expiration, the initial 400 ml from large airways was discarded using a pressure-sensitive one-way valve, the remainder flowed to a 750 ml collection bag. Ambient samples from the participants’ rooms were collected simultaneously into separate 750 ml bags. Air samples were analyzed using a gas chromatograph with a reduction gas detector at a precision of 5 ppb (PeakPerformer1RCP, Peak Laboratories, CA)84.

Each molecule of biliverdin from heme degradation is conjugated in the liver to bilirubin, excreted in the intestine, converted to urobilinoids and eliminated in the feces41. We collected stools over 3-day periods before bed rest (BDC-13,-12,-11), four times during bed rest (HDT11,12,13, HDT30,31,32, HDT56,57,58) and at reambulation (R5,6,7). Stools were protected from light and immediately frozen at −20 °C. Later, each sample was thawed, weighed, homogenized and a 350 mg aliquot was suspended with 16 mM NaCl. Urobilinoids were extracted from 0.4 ml of the suspension according to Kotal41. Briefly, the suspension was oxidized by Lugol iodine. Adding 54 mM zinc acetate in dimethyl sulfoxide formed a zinc complex and 82 mM of cysteine was added. The extraction process was repeated twice. The absorption of the zinc complex of oxidized urobilinoids at 508 nm was compared to a standard curve using photometry (Infinite200PRO, Tecan, Switzerland).

Total hemoglobin mass was measured using CO-rebreathing at baseline (BDC-4), at the end of bed rest (HDT60) and at reambulation (R7) according to Burge85. Briefly, participants breathed pure oxygen for 5 min before a baseline measure of carboxyhemoglobin. The participants then received an individualized dose of CO (50–90 ml) rebreathed for 10 min before a second measure of carboxyhemoglobin. THb was calculated using carboxyhemoglobin kinetics. Importantly, since exogenous CO washout requires 2–6 h86,87,88,89, we measured CO elimination at least 3 days after each tHb measures (Supplementary Fig. 4).

Blood samples were collected at 07 h30 min at BDC-4, HDT20, HDT49, R13, and R30 and processed at Laboratoire Biopole, France (Accreditation 31.3.31158.1) for total bilirubin, serum iron, saturation of transferrin, EPO, and haptoglobin. RBC, Hb, and reticulocyte concentrations were sampled at the same time points plus at HDT60 and R1 (Supplementary Fig. 5). Since all baseline measures but one were carried between BDC-4 and BDC-1, they corresponded to the status within 4 days of the bed rest phase. The one measure outside that range was the 3-day stool collection of urobilinoids (from BDC-13 to BDC-11). All measures were performed blindly except for CO where the type of sample (ambient or alveolar) was disclosed in order to calibrate accordingly.

Statistical methods

There were 16 investigator groups each with primary and secondary outcomes. For our experiment, CO elimination constituted the primary outcome. The effect of nutritional intervention was assessed using Mann Whitney U-tests. For the primary outcome measure (CO elimination) and all outcomes, data with 95% confidence interval are presented in Tables 1 and 2. For the primary outcome measure (CO elimination) and all outcomes, change from baseline with 95% confidence interval are presented in Results, and Figs 2 and 3. Paired t-test were ran between baseline and experimental time points with no correction for multiple testing.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

Data will be made available upon reasonable request to the corresponding author.


  1. Fischer, C. L., Johnson, P. C. & Berry, C. A. Red blood cell mass and plasma volume changes in manned space flight. JAMA 200, 579–583 (1967).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  2. Leach, C. & Johnson, P. Influence of spaceflight on erythrokinetics in man. Science 225, 216–218 (1984).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  3. Udden, M. M., Driscoll, T. B., Pickett, M. H., Leach-Huntoon, C. S. & Alfrey, C. P. Decreased production of red blood cells in human subjects exposed to microgravity. J. Lab. Clin. Med. 125, 442–449 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Alfrey, C. P., Udden, M. M., Leach-Huntoon, C., Driscoll, T. & Pickett, M. H. Control of red blood cell mass in spaceflight. J. Appl. Physiol. 81, 98–104 (1996).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. Kunz, H. et al. Alterations in hematologic indices during long-duration spaceflight. BMC Hematol. 17, 1–8 (2017).

    Article  CAS  Google Scholar 

  6. Trudel, G., Shafer, J., Laneuville, O. & Ramsay, T. Characterizing the effect of exposure to microgravity on anemia: more space is worse. Am. J. Hematol. 95, 267–273 (2020).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. Tavassoli, M. Anemia of spaceflight. Blood 60, 1059–1067 (1982).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  8. Blaber, E. A. et al. Microgravity reduces the differentiation and regenerative potential of embryonic stem cells. Stem Cells Dev. 24, 2605–2621 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. Ivanova, S. M. et al. Physical–chemical properties of plasma membrane and function of erythrocytes of cosmonauts after long-term space flight. Acta Astronaut. 68, 1517–1522 (2011).

    CAS  Article  Google Scholar 

  10. Risso, A., Ciana, A., Achilli, C., Antonutto, G. & Minetti, G. Neocytolysis: none, one or many? A reappraisal and future perspectives. Front. Physiol. 5, 54 (2014).

    PubMed  PubMed Central  Article  Google Scholar 

  11. Damulewicz, M., Loboda, A., Jozkowicz, A., Dulak, J. & Pyza, E. Interactions between the circadian clock and heme oxygenase in the retina of Drosophila melanogaster. Mol. Neurobiol. 54, 4953–4962 (2017).

    CAS  PubMed  Article  Google Scholar 

  12. Landaw, S. A., Callahan, E. W. & Schmid, R. Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide. J. Clin. Invest. 49, 914–925 (1970).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. Karabulut, B. & Arcagok, B. C. A neglected and promising predictor of severe hyperbilirubinemia due to hemolysis: carboxyhemoglobin. Fetal Pediatr. Pathol. 39, 124–131 (2020).

    PubMed  Article  Google Scholar 

  14. Franco, R. S. The measurement and importance of red cell survival. Am. J. Hematol. 84, 109–114 (2009).

    PubMed  Article  Google Scholar 

  15. Trudel, G., Uhthoff, H. K. & Laneuville, O. Hemolysis during and after 21 days of head-down-tilt bed rest. Physiol. Rep. 5, e13469 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  16. Dunn, C. D. R., Lange, R. D., Kimzey, S. L., Johnson, P. C. & Leach, C. S. Serum erythropoietin titers during prolonged bedrest; relevance to the anaemia of space flight. Eur. J. Appl. Physiol. Occup. Physiol. 52, 178–182 (1984).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  17. Lampe, L. et al. Effects of simulated microgravity (HDT) on blood fluidity. J. Appl. Physiol. 73, 1366–1369 (1992).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  18. Parry, S. M. & Puthucheary, Z. A. The impact of extended bed rest on the musculoskeletal system in the critical care environment. Extrem. Physiol. Med. 4, 1–8 (2015).

    Article  Google Scholar 

  19. Chant, C., Wilson, G. & Friedrich, J. O. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit. Care 10, R140 (2006).

    PubMed  PubMed Central  Article  Google Scholar 

  20. Rodriguez, R. M. et al. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J. Crit. Care 16, 36–41 (2001).

    CAS  PubMed  Article  Google Scholar 

  21. Napolitano, L. M. Anemia and red blood cell transfusion. Crit. Care Clin. 33, 345–364 (2017).

    PubMed  Article  Google Scholar 

  22. Docherty, A. B., Turgeon, A. F. & Walsh, T. S. Best practice in critical care: anaemia in acute and critical illness. Transfus. Med. 28, 181–189 (2018).

    CAS  PubMed  Article  Google Scholar 

  23. Thomas, J., Jensen, L., Nahirniak, S. & Gibney, R. T. N. Anemia and blood transfusion practices in the critically ill: a prospective cohort review. Hear. Lung 39, 217–225 (2010).

    Article  Google Scholar 

  24. Leal-Noval, S. R. et al. Effects of red blood cell transfusion on long-term disability of patients with traumatic brain injury. Neurocrit. Care 24, 371–380 (2016).

    CAS  PubMed  Article  Google Scholar 

  25. Perkash, A. & Brown, M. Anemia in patients with traumatic spinal cord injury. J. Am. Paraplegia Soc. 9, 10–15 (1986).

    CAS  PubMed  Article  Google Scholar 

  26. Milionis, H. et al. Anemia on admission predicts short- and long-term outcomes in patients with acute ischemic stroke. Int. J. Stroke 10, 224–230 (2015).

    PubMed  Article  Google Scholar 

  27. Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G. & Woodman, R. C. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104, 2263–2268 (2004).

    CAS  PubMed  Article  Google Scholar 

  28. Patel, K. V. Epidemiology of anemia in older adults. Semin. Hematol. 45, 210–217 (2008).

    PubMed  PubMed Central  Article  Google Scholar 

  29. Artz, A. S. et al. Prevalence of anemia in skilled-nursing home residents. Arch. Gerontol. Geriatr. 39, 201–206 (2004).

    PubMed  Article  Google Scholar 

  30. Prakash, D. Anemia in the ICU. Crit. Care Clin. 28, 333–343 (2012).

    PubMed  Article  PubMed Central  Google Scholar 

  31. Weiss, G., Ganz, T. & Goodnough, L. T. Anemia of inflammation. Blood 133, 40–50 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  32. Ganz, T. Anemia of Inflammation. N. Engl. J. Med. 381, 1148–1157 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  33. Anía, B. J., Suman, V. J., Fairbanks, V. F., Rademacher, D. M.III., & Melton, L. J. Incidence of anemia in older people: an epidemiologic study in a well defined population. J. Am. Geriatr. Soc. 45, 825–831 (1997).

    PubMed  Article  PubMed Central  Google Scholar 

  34. Mugisha, J. O., Baisley, K., Asiki, G., Seeley, J. & Kuper, H. Prevalence, types, risk factors and clinical correlates of anaemia in older people in a rural ugandan population. PLoS ONE 8, e78394 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. Semba, R. D. et al. Types of anemia and mortality among older disabled women living in the community: the Women’s Health and Aging Study I. Aging Clin. Exp. Res. 19, 259–264 (2007).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. Zwart, S. R., Pierson, D., Mehta, S., Gonda, S. & Smith, S. M. Capacity of omega-3 fatty acids or eicosapentaenoic acid to counteract weightlessness-induced bone loss by inhibiting NF-kappaB activation: from cells to bed rest to astronauts. J. Bone Miner. Res. 25, 1049–1057 (2010).

    CAS  PubMed  Google Scholar 

  37. Smith, G. I. et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am. J. Clin. Nutr. 93, 402–412 (2011).

    CAS  PubMed  Article  Google Scholar 

  38. Momken, I. et al. Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. FASEB J. 25, 3646–3660 (2011).

    CAS  PubMed  Article  Google Scholar 

  39. Sjöstrand, T. The formation of carbon monoxide by the decomposition of haemoglobin in vivo. Acta Physiol. Scand. 26, 338–344 (1952).

    PubMed  Article  Google Scholar 

  40. Coburn, R. F. The measurement of endogenous carbon monoxide production. J. Appl. Physiol. 112, 1949–1955 (2012).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  41. Kotal, P. & Fevery, J. Quantitation of urobilinogen in feces, urine, bile and serum by direct spectrophotometry of zinc complex. Clin. Chim. Acta 202, 1–9 (1991).

    CAS  PubMed  Article  Google Scholar 

  42. Bloomer, J. R., Berk, P. D., Howe, R. B. & Berlin, N. I. Interpretation of plasma on studies with radiobilirubin. JAMA J. Am. Med. Assoc. 218, 216 (1971).

    CAS  Article  Google Scholar 

  43. Shi, H., Bencze, K. Z., Stemmler, T. L. & Philpott, C. C. A Cytosolic iron chaperone that delivers iron to ferritin. Science 320, 1207–1210 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. Levitt, D. G. & Levitt, M. D. Carbon monoxide: a critical quantitative analysis and review of the extent and limitations of its second messenger function. Clin. Pharmacol. 7, 37–56 (2015).

    PubMed  PubMed Central  Google Scholar 

  45. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 1–6 (WHO, 2011).

  46. De Santo, N. G. et al. Anemia and Erythropoietin in Space Flights. Semin. Nephrol. 25, 379–387 (2005).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  47. Alfrey, C. P., Rice, L., Udden, M. M. & Driscoll, T. B. Neocytolysis: physiological down-regulator of red-cell mass. Lancet 349, 1389–1390 (1997).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. Rice, L. & Alfrey, C. The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell. Physiol. Biochem. 15, 245–250 (2005).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  49. Socolovsky, M. Exploring the erythroblastic island. Nat. Med. 19, 399–401 (2013).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  50. Kristiansen, M. et al. Identification of the haemoglobin scavenger receptor. Nature 409, 198–201 (2001).

    CAS  PubMed  Article  Google Scholar 

  51. Schaer, D. J., Vinchi, F., Ingoglia, G., Tolosano, E. & Buehler, P. W. Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front. Physiol. 5, 415 (2014).

    PubMed  PubMed Central  Article  Google Scholar 

  52. Shih, A. W. Y., McFarlane, A. & Verhovsek, M. Haptoglobin testing in hemolysis: measurement and interpretation. Am. J. Hematol. 89, 443–447 (2014).

    CAS  PubMed  Article  Google Scholar 

  53. Kunisaki, Y. et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637–643 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. Adler, B. J., Kaushansky, K. & Rubin, C. T. Obesity-driven disruption of haematopoiesis and the bone marrow niche. Nat. Rev. Endocrinol. 10, 737–748 (2014).

    CAS  PubMed  Article  Google Scholar 

  55. Pinho, S. & Frenette, P. S. Haematopoietic stem cell activity and interactions with the niche. Nat. Rev. Mol. Cell Biol. 20, 303–320 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  56. Dimeo, F., Knauf, W., Geilhaupt, D. & Böning, D. Endurance exercise and the production of growth hormone and haematopoietic factors in patients with anaemia. Br. J. Sports Med. 38, e37 (2004).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  57. Moretti, D. et al. An intensified training schedule in recreational male runners is associated with increases in erythropoiesis and inflammation and a net reduction in plasma hepcidin. Am. J. Clin. Nutr. 108, 1324–1333 (2018).

    PubMed  Article  Google Scholar 

  58. Payne, M. W. C., Uhthoff, H. K. & Trudel, G. Anemia of immobility: Caused by adipocyte accumulation in bone marrow. Med. Hypotheses 69, 778–786 (2007).

    CAS  PubMed  Article  Google Scholar 

  59. Turner, R. T., Martin, S. A. & Iwaniec, U. T. Metabolic coupling between bone marrow adipose tissue and hematopoiesis. Curr. Osteoporos. Rep. 16, 95–104 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  60. Zhang, Z. et al. Bone marrow adipose tissue-derived stem cell factor mediates metabolic regulation of hematopoiesis. Haematologica 104, 1731–1743 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  61. Suresh, S., de Castro, L. F., Dey, S., Robey, P. G. & Noguchi, C. T. Erythropoietin modulates bone marrow stromal cell differentiation. Bone Res. 7, 21 (2019).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  62. Robles, H. et al. Characterization of the bone marrow adipocyte niche with three-dimensional electron microscopy. Bone 118, 89–98 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  63. Yokoyama, T., Etoh, T., Kitagawa, H., Tsukahara, S. & Kannan, Y. Migration of erythroblastic islands toward the sinusoid as erythroid maturation proceeds in rat bone marrow. J. Vet. Med. Sci. 65, 449–452 (2003).

    PubMed  Article  Google Scholar 

  64. Kaasik, K. & Chi Lee, C. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 430, 467–471 (2004).

    CAS  PubMed  Article  Google Scholar 

  65. Yin, L. et al. Rev-erb, a heme sensor that coordinates metabolic and circadian pathways. Science (80-) 318, 1786–1789 (2007).

    CAS  Article  Google Scholar 

  66. Freeman, S. L. et al. Heme binding to human CLOCK affects interactions with the E-box. Proc. Natl Acad. Sci. U.S.A. 116, 19911–19916 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. Dioum, E. M. et al. NPAS2: a gas-responsive transcription factor. Science (80-.) 298, 2385–2387 (2002).

    CAS  Article  Google Scholar 

  68. Gachon, F., Olela, F. F., Schaad, O., Descombes, P. & Schibler, U. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab. 4, 25–36 (2006).

    CAS  PubMed  Article  Google Scholar 

  69. Panda, S. Circadian physiology of metabolism. Science 354, 1008–1015 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  70. Klemz, R. et al. Reciprocal regulation of carbon monoxide metabolism and the circadian clock. Nat. Struct. Mol. Biol. 24, 15–22 (2017).

    CAS  Article  Google Scholar 

  71. Vincent, J. L. et al. Anemia and blood transfusion in critically Ill patients. JAMA 288, 1499 (2002).

    PubMed  Article  PubMed Central  Google Scholar 

  72. New, P. W., Rawicki, H. B. & Bailey, M. J. Nontraumatic spinal cord injury rehabilitation: pressure ulcer patterns, prediction, and impact. Arch. Phys. Med. Rehabil. 85, 87–93 (2004).

    PubMed  Article  PubMed Central  Google Scholar 

  73. Chan, T. & Ganasekaran, G. The effect of anemia on the functional outcomes of the stroke patients and the efficiency of their stroke rehabilitation. J. Stroke Cerebrovasc. Dis. 24, 1438–1442 (2015).

    PubMed  Article  PubMed Central  Google Scholar 

  74. Halawi, R., Moukhadder, H. & Taher, A. Anemia in the elderly: a consequence of aging? Expert Rev. Hematol. 10, 327–335 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  75. Mitlyng, B. L., Singh, J. A., Furne, J. K., Ruddy, J. & Levitt, M. D. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am. J. Hematol. 81, 432–438 (2006).

    PubMed  Article  PubMed Central  Google Scholar 

  76. Lestar, M., Gunnarsson, L., Lagerstrand, L., Wiklund, P. & Odeberg-Wernerman, S. Hemodynamic perturbations during robot-assisted laparoscopic radical prostatectomy in 45° Trendelenburg position. Anesth. Analg. 113, 1069–1075 (2011).

    PubMed  Article  PubMed Central  Google Scholar 

  77. Berney, S., Denehy, L. & Pretto, J. Head-down tilt and manual hyperinflation enhance sputum clearance in patients who are intubated and ventilated. Aust. J. Physiother. 50, 9–14 (2004).

    PubMed  Article  PubMed Central  Google Scholar 

  78. Choi, Y. S. et al. Effects of head-down tilt on intrapulmonary shunt fraction and oxygenation during one-lung ventilation in the lateral decubitus position. J. Thorac. Cardiovasc. Surg. 134, 613–618 (2007).

    PubMed  Article  PubMed Central  Google Scholar 

  79. Hirose, M., Hashimoto, S. & Tanaka, Y. Effect of the head-down tilt position during lower abdominal surgery on endocrine and renal function response. Anesth. Analg. 76, 40–44 (1993).

    CAS  PubMed  Article  Google Scholar 

  80. Hayden, S. J., Albert, T. J., Watkins, T. R. & Swenson, E. R. Anemia in critical illness. Am. J. Respir. Crit. Care Med 185, 1049–1057 (2012).

    PubMed  PubMed Central  Article  Google Scholar 

  81. Brusotti, G. et al. Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis. Sci. Rep. 7, 5777 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  82. Strewe, C. et al. PlanHab study: consequences of combined normobaric hypoxia and bed rest on adenosine kinetics. Sci. Rep. 8, 1–9 (2018).

    CAS  Article  Google Scholar 

  83. Shahin, N., Louati, H. & Trudel, G. Measuring human hemolysis clinically and in extreme environments using endogenous carbon monoxide elimination. Ann. Biomed. Eng. 48, 1540–1550 (2020).

    PubMed  Article  Google Scholar 

  84. Peak Laboratories. Peak Performer 1 RCP (910-Series) User Manual (Peak Laboratories, 2008).

  85. Burge, C. M. & Skinner, S. L. Determination of hemoglobin mass and blood volume with CO: evaluation and application of a method. J. Appl. Physiol. 79, 623–631 (1995).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  86. Zavorsky, G. S. et al. Rates of carbon monoxide elimination in males and females. Physiol. Rep. 2, 1–10 (2014).

    Google Scholar 

  87. Levasseur, L., Galliot-Guilley, M., Richter, F., Scherrmann, J. M. & Baud, F. J. Effects of mode of inhalation of carbon monoxide and of normobaric oxygen administration on carbon monoxide elimination from the blood. Hum. Exp. Toxicol. 15, 898–903 (1996).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  88. Bruce, M. C. & Bruce, E. N. Analysis of factors that influence rates of carbon monoxide uptake, distribution, and washout from blood and extravascular tissues using a multicompartment model. J. Appl. Physiol. 100, 1171–1180 (2006).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  89. Garvican, L. A. et al. Carbon monoxide uptake kinetics of arterial, venous and capillary blood during CO rebreathing. Exp. Physiol. 95, 1156–1166 (2010).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

Download references


We would like to thank the volunteers for their participation, the staff at the Medes Institute for Space Medicine and Physiology especially Marie-Pierre Bareille, Arnaud Beck, Marie-Claude Costes-Salon, Patrick Person, and Corinne Lombard for support during the study, Doug Worthy and Michele Rauh from the Canadian Green House Gases program, Theresa Backlund, Téa Backlund, Nibras Shahin, and Justin Thomas for their assistance with the CO and urobilinoids measures, Carolynn Cook for the graphs and Dr. Hans Uhthoff with the critical review of the manuscript. The bed rest study was funded by the European Space Agency, the Center National d’Etudes Spatiales and the Canadian Space Agency (CSA). Investigators costs were covered under CSA grant 15EXPBEDST. The European Space Agency established the study design, dates, sample size, and duration of the bed rest study. Funders had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author information




Concept and design: G.T. Acquisition, analysis, or interpretation of data: G.T., K.C., O.L., H.L., T.R. Drafting of the manuscript: G.T., K.C. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: K.C., T.R., G.T. Obtained funding: G.T., O.L.

Corresponding author

Correspondence to Guy Trudel.

Ethics declarations

Competing interests

The authors declare the following competing interests: Dr. G.T. has received funding from the Canadian Space Agency to conduct this and other experiments. No other competing interests were reported by the other authors.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Culliton, K., Louati, H., Laneuville, O. et al. Six degrees head-down tilt bed rest caused low-grade hemolysis: a prospective randomized clinical trial. npj Microgravity 7, 4 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing